Literature DB >> 13746011

Immunoenzymological evidence suggesting a change in conformation of adenylic acid deaminase and creatine kinase during substrate combination.

A J SAMUELS.   

Abstract

The kinetics of inhibition of 5'-adenylic acid deaminase and creatine-ATP transphosphorylase by their respective antibodies are studied and rate constants of combination are ascertained. It is shown that the single substrate 5'-adenylic acid (AMP) of deaminase "protects" the enzyme against antibody inhibition. However, phosphate, a competitive inhibitor of the highly specific deaminase, enhances combination with antibody. With creatine kinase, however, addition of either of the substrates, alone or in combination with the required magnesium, each of which separately bind to the enzyme, does not prevent inhibition of the enzyme by its antibody. However, the "working" enzyme combined with all substrates is "protected" against antibody inhibition.

Entities:  

Keywords:  AMIDASES/chemistry; KINASES/chemistry

Mesh:

Substances:

Year:  1961        PMID: 13746011      PMCID: PMC1366332          DOI: 10.1016/s0006-3495(61)86901-4

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  11 in total

1.  The immuno-enzymology of muscle proteins. I. General features of myosin and 5'-adenylic acid deaminase.

Authors:  A SAMUELS
Journal:  Arch Biochem Biophys       Date:  1961-03       Impact factor: 4.013

2.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

3.  Interaction between myosin and its substrates.

Authors:  J J BLUM
Journal:  Arch Biochem Biophys       Date:  1960-03       Impact factor: 4.013

4.  Antibodies against enzymes.

Authors:  B CINADER
Journal:  Annu Rev Microbiol       Date:  1957       Impact factor: 15.500

5.  5'-Adenylic acid deaminase. III. Properties and kinetic studies.

Authors:  Y P LEE
Journal:  J Biol Chem       Date:  1957-08       Impact factor: 5.157

6.  Alterations in metabolism during electrical excitation of frog nerve.

Authors:  A SAMUELS
Journal:  Am J Physiol       Date:  1957-08

7.  The correlation of ribonuclease activity with specific aspects of tertiary structure.

Authors:  M SELA; C B ANFINSEN; W F HARRINGTON
Journal:  Biochim Biophys Acta       Date:  1957-12

8.  Adenosinetriphosphate-creatine transphosphorylase. III. Kinetic studies.

Authors:  S A KUBY; L NODA; H A LARDY
Journal:  J Biol Chem       Date:  1954-09       Impact factor: 5.157

9.  The effect of a specific antiserum on the activities of lactic dehydrogenase of mammalian muscle and of Schistosoma mansoni.

Authors:  T E MANSOUR; E BUEDING; A B STAVITSKY
Journal:  Br J Pharmacol Chemother       Date:  1954-06

10.  ANOMALOUS OPTICAL ROTATORY DISPERSION OF DYE: POLYPEPTIDE COMPLEXES.

Authors:  E R Blout; L Stryer
Journal:  Proc Natl Acad Sci U S A       Date:  1959-11       Impact factor: 11.205

View more
  4 in total

1.  Crystal structure of brain-type creatine kinase at 1.41 A resolution.

Authors:  M Eder; U Schlattner; A Becker; T Wallimann; W Kabsch; K Fritz-Wolf
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  A study of the 'reactive' sulphydryl groups of adenosine 5'-triphosphate-creatine phosphotransferase.

Authors:  D C WATTS; B R RABIN
Journal:  Biochem J       Date:  1962-12       Impact factor: 3.857

3.  Monoclonal antibody studies of creatine kinase. Antibody-binding sites in the N-terminal region of creatine kinase and effects of antibody on enzyme refolding.

Authors:  G E Morris; L C Frost; P A Newport; N Hudson
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

4.  Properties and reaction with iodoacetamide of adenosine 5'-triphosphate-creatine phosphotransferase from human skeletal muscle. Further evidence about the role of the essential thiol group in relation to the mechanism of action.

Authors:  I Kumudavalli; B H Moreland; D C Watts
Journal:  Biochem J       Date:  1970-04       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.